tiprankstipranks
Trending News
More News >
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
FRANKFURT:818
Germany Market
Advertisement

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (818) Dividend Date & History

Compare
1 Followers
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.12 (7.31%)
$94.64B
10.76
+4.66%
3 Buy
3 Hold
1 Sell
Moderate Buy
$1.11 (4.48%)
$176.97B
8.05
+11.89%
11 Buy
5 Hold
0 Sell
Moderate Buy
$0.425 (12.8%)
$417.75M
-0.42
-59.95%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.7 (2.18%)
$287.35B
36.77
+47.62%
7 Buy
6 Hold
1 Sell
Moderate Buy
$6.76 (4.29%)
$322.91B
22.27
+3.04%
11 Buy
5 Hold
0 Sell
Moderate Buy
$3.945 (3.73%)
$57.79B
10.29
-12.41%
12 Buy
13 Hold
0 Sell
Moderate Buy
$1.305 (7.75%)
$57.77B
12.99
+2.43%
10 Buy
1 Hold
0 Sell
Strong Buy
$2.833 (8.34%)
$7.13B
12.60
-1.91%
1 Buy
7 Hold
0 Sell
Hold
$1.92 (9.43%)
$14.57B
10.22
-3.09%
8 Buy
2 Hold
0 Sell
Strong Buy

FAQ

How much is Zylox-Tonbridge Medical Technology Co., Ltd. Class H's dividend?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818) does not pay a dividend
When is Zylox-Tonbridge Medical Technology Co., Ltd. Class H ex-dividend date?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818) does not pay a dividend.
When is Zylox-Tonbridge Medical Technology Co., Ltd. Class H dividend payment date?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818) does not pay a dividend.
Does Zylox-Tonbridge Medical Technology Co., Ltd. Class H have sufficient earnings to cover their dividend?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818) does not pay a dividend.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis